The Ubiquitin Proteasome System in ER Quality Control

ER 质量控制中的泛素蛋白酶体系统

基本信息

  • 批准号:
    7887688
  • 负责人:
  • 金额:
    $ 50.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-05-01 至 2014-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term goal of this project is to elucidate the mechanisms by which proteins in the secretory pathway are recognized and destroyed by the ubiquitin-proteasome system (UPS) in a process known as endoplasmic reticulum-associated degradation (ERAD). Substrates committed to this fate are diverse, and include secreted and integral membrane proteins that are unable to fold correctly as a consequence of mutation or inefficient assembly into oligomeric complexes. During the current funding period we have made exceptional progress in achieving our primary aims of establishing a robust and versatile functional genomics platform to map functional substrate-specific sub-networks within the mammalian ERAD system, and have exceeded these aims in developing powerful proteomic tools that have enabled us to compile a preliminary map of the mammalian ERAD interactome. The present application proposes to expand these achievements with the goal of defining the role of chaperones and glycans in luminal ER quality control surveillance and to develop a comprehensive understanding of the composition and functional organization of the ERAD system in mammals. These goals are defined three specific aims. The first specific aim will employ established biochemical, cell biological and biophysical methodology to define the mechanisms by which substrates are committed to ERAD pathway and the role of the molecular chaperone, GRP94, in this process. The second specific aim will conduct a large-scale comprehensive functional genomic screen of the entire UPS in the degradation of a set of topologically diverse ERAD substrates and will validate these components using a battery of informatic and biochemical tools. The third specific aim is to construct a comprehensive map of the mammalian ERAD network by combining in-depth mining of the ERAD proteome with gene silencing to identify network topology, and to overlay this map on the substrate-specific functional network generated in Aim 2. These studies are focused on elucidating the molecular mechanisms by which folding or assembly-defective proteins are destroyed by mammalian cells, and therefore, have direct bearing on human health. PUBLIC HEALTH RELEVANCE: The proposed studies will investigate the process by which misfolded or damaged proteins in the secretory pathway are identified and destroyed. Since mutations which influence protein folding underlie most genetic diseases, understanding the cellular mechanisms that defend against such mutations is critical to our understanding of the molecular basis of genetic disease.
描述(由申请人提供):该项目的长期目标是阐明分泌途径中的蛋白质在称为内质网相关降解(ERAD)的过程中被泛素蛋白酶体系统(UPS)识别和破坏的机制。导致这种命运的底物是多种多样的,包括分泌型膜蛋白和整合膜蛋白,这些蛋白由于突变或低效组装成寡聚复合物而无法正确折叠。在当前的资助期间,我们在实现我们的主要目标方面取得了非凡的进展,即建立一个强大且多功能的功能基因组学平台,以绘制哺乳动物 ERAD 系统内的功能底物特异性子网络,并且在开发强大的蛋白质组学工具方面超越了这些目标,使我们能够编制哺乳动物 ERAD 相互作用组的初步图谱。本申请提出扩大这些成就,目标是确定伴侣和聚糖在管腔 ER 质量控制监测中的作用,并全面了解哺乳动物 ERAD 系统的组成和功能组织。这些目标定义了三个具体目标。第一个具体目标将采用已建立的生物化学、细胞生物学和生物物理方法来定义底物参与 ERAD 途径的机制以及分子伴侣 GRP94 在此过程中的作用。第二个具体目标是对整个 UPS 在一组拓扑多样的 ERAD 底物的降解过程中进行大规模综合功能基因组筛选,并使用一系列信息学和生化工具验证这些组件。第三个具体目标是通过对 ERAD 蛋白质组的深入挖掘与基因沉默相结合来识别网络拓扑,构建哺乳动物 ERAD 网络的综合图谱,并将该图谱叠加到目标 2 中生成的底物特异性功能网络上。这些研究重点是阐明哺乳动物细胞破坏折叠或组装缺陷蛋白的分子机制,因此具有直接意义。 对人类健康。 公共健康相关性:拟议的研究将调查分泌途径中错误折叠或受损蛋白质被识别和破坏的过程。由于影响蛋白质折叠的突变是大多数遗传病的基础,因此了解防御此类突变的细胞机制对于我们了解遗传病的分子基础至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RON R KOPITO其他文献

RON R KOPITO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RON R KOPITO', 18)}}的其他基金

The role of UFMylation in ribosome quality control at the ER
UFMylation 在 ER 核糖体质量控制中的作用
  • 批准号:
    10561470
  • 财政年份:
    2023
  • 资助金额:
    $ 50.74万
  • 项目类别:
Protein Aggregation and Inclusion Body Formation
蛋白质聚集和包涵体形成
  • 批准号:
    8686087
  • 财政年份:
    2012
  • 资助金额:
    $ 50.74万
  • 项目类别:
Protein Aggregation and Inclusion Body Formation
蛋白质聚集和包涵体形成
  • 批准号:
    9098811
  • 财政年份:
    2012
  • 资助金额:
    $ 50.74万
  • 项目类别:
Protein Aggregation and Inclusion Body Formation
蛋白质聚集和包涵体形成
  • 批准号:
    8401724
  • 财政年份:
    2012
  • 资助金额:
    $ 50.74万
  • 项目类别:
Protein Aggregation and Inclusion Body Formation
蛋白质聚集和包涵体形成
  • 批准号:
    8490454
  • 财政年份:
    2012
  • 资助金额:
    $ 50.74万
  • 项目类别:
The Ubiquitin Proteasome System in ER Quality Control
ER 质量控制中的泛素蛋白酶体系统
  • 批准号:
    8462992
  • 财政年份:
    2006
  • 资助金额:
    $ 50.74万
  • 项目类别:
The ubiquitin proteasome system in ER quality control
内质网质量控制中的泛素蛋白酶体系统
  • 批准号:
    9912161
  • 财政年份:
    2006
  • 资助金额:
    $ 50.74万
  • 项目类别:
The Ubiquitin Proteasome System in ER Quality Control
ER 质量控制中的泛素蛋白酶体系统
  • 批准号:
    8260579
  • 财政年份:
    2006
  • 资助金额:
    $ 50.74万
  • 项目类别:
The ubiquitin proteasome system in ER quality control
内质网质量控制中的泛素蛋白酶体系统
  • 批准号:
    10193992
  • 财政年份:
    2006
  • 资助金额:
    $ 50.74万
  • 项目类别:
The Ubiquitin Proteasome System in Quality Control
泛素蛋白酶体系统在质量控制中的应用
  • 批准号:
    7616236
  • 财政年份:
    2006
  • 资助金额:
    $ 50.74万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 50.74万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 50.74万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.74万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.74万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 50.74万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.74万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 50.74万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 50.74万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 50.74万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.74万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了